e-learning
resources
Amsterdam 2011
Wednesday, 28.09.2011
Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diagnostic value of bronchoalveolar lavage and lymphocyte transformation test in drug-induced lung disease
Y. Kimizuka, S. Tasaka, W. Yamasawa, M. Ishii, H. Kamata, H. Fujiwara, Y. Funatsu, H. Namkoong, N. Hasegawa, M. Murata, K. Asano (Tokyo, Japan)
Source:
Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Session:
Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Session type:
Poster Discussion
Number:
4768
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Kimizuka, S. Tasaka, W. Yamasawa, M. Ishii, H. Kamata, H. Fujiwara, Y. Funatsu, H. Namkoong, N. Hasegawa, M. Murata, K. Asano (Tokyo, Japan). Diagnostic value of bronchoalveolar lavage and lymphocyte transformation test in drug-induced lung disease. Eur Respir J 2011; 38: Suppl. 55, 4768
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Diagnostic value of total cell count in bronchoalveolar lavage fluid from patients with interstitial lung diseases
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009
Diagnostic value of broncho-alveolar lavage in pulmonary neoplasy
Source: Eur Respir J 2002; 20: Suppl. 38, 276s
Year: 2002
Diagnostic value of tumor markers and cells population in bronchoalveolar lavage in lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 37s
Year: 2003
Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases
Source: Eur Respir J 2004; 24: 1000-1006
Year: 2004
Bronchoalveolar lavage differential cell count on assessment of patients with pulmonary fibrosis
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020
The importance of cytological analysis of bronchoalveolar lavage in tuberculous lung disease
Source: Eur Respir J 2007; 30: Suppl. 51, 662s
Year: 2007
Characterization of the lymphocyte phenotype in bronchoalveolar lavage as a prognostic marker in pulmonary sarcoidosis
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Year: 2019
Comparison of induced sputum and bronchoalveolar lavage cell differential in patients with sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 508s
Year: 2001
Bronchoalveolar lavage: how can we use it more effectively to define pathology?
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006
The role of bronchoalveolar lavage cellular analysis in the diagnosis of interstitial lung diseases
Source: Eur Respir Mon; 2009: 46: 36–46
Year: 2009
Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis
Source: Eur Respir J 2003; 21: 407-413
Year: 2003
Bronchoalveolar lavage immunophenotyping improves diagnostic accuracy in patients with diffuse parenchymal lung disease
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010
Diagnostic value of cryobiopsy in patients with interstitial lung diseases integrating bronchoalveolar lavage, radiologic and clinical data
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020
Diagnostic value of bronchoalveolar lavage (BAL) in sputum smear negative pulmonary tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Is the severity of newly diagnosed pulmonary sarcoidosis reflected by bronchoalveolar lavage (BAL) parameters?
Source: Eur Respir J 2002; 20: Suppl. 38, 468s
Year: 2002
Is the severity of newly diagnosed pulmonary sarcoidosis reflected by bronchoalveolar lavage (BAL) parameters?
Source: Eur Respir J 2001; 18: Suppl. 33, 507s
Year: 2001
Diagnostic value of pneumocystis-PCR in bronchoalveolar lavage in a clinical setting
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
Infrequent apoptosis of bronchoalveolar lavage lymphocytes (L-BALs) in pneumoconioses
Source: Eur Respir J 2004; 24: Suppl. 48, 146s
Year: 2004
Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients
Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation
Year: 2008
The repeatability of nonbronchoscopic bronchoalveolar lavage differential cell counts
Source: Eur Respir J 2001; 18: 1009-1012
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept